Local drug disposal may kill small biotechs says BIO, as Bay area county votes in favour
This article was originally published in Scrip
A local government agency in the San Francisco Bay Area wants to implement a first-of-its-kind ordinance that would require biotechnology and pharmaceutical companies to pay for the collection and disposal of unused prescription and over-the-counter medications in Alameda County to prevent pollution and drug abuse.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Olema launched this year’s 76th US biopharma IPO. Also, investments in regenerative medicines reached a new high, Qiming closed a $1.2bn China-focused VC fund, D3 Bio led recent venture deals with a $200m round, and Bausch sold $2bn worth of notes to pay down near-term debts.